56.30
3.32%
1.81
시간 외 거래:
56.30
Apogee Therapeutics Inc (APGE) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-09-30 |
기간 | 3개월 | 3개월 |
Revenues |
-
|
- |
Operating Expenses
|
57.09%
38.18
|
24.30 |
Operating Income/Loss |
57.09%
-38.18
|
-24.30 |
Income/Loss From Continuing Operations Before Tax |
54.00%
-32.09
|
-20.84 |
Income/Loss From Continuing Operations After Tax |
54.00%
-32.09
|
-20.84 |
Net Income/Loss
|
54.00%
-32.09
|
-20.84 |
Preferred Stock Dividends And Other Adjustments |
-
|
- |
Attributable To Noncontrolling Interest |
-
|
- |
Basic Average Shares |
21.73%
50.19
|
41.23 |
Diluted Average Shares |
21.73%
50.19
|
41.23 |
Basic Earnings Per Share |
25.49%
-0.64
|
-0.51 |
Diluted Earnings Per Share |
25.49%
-0.64
|
-0.51 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
자본화:
|
볼륨(24시간):